Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2233 (LINC02233) is a long non-coding RNA (lncRNA), specifically classified as a long intergenic non-coding RNA (lincRNA), meaning it is transcribed from regions of the genome outside of protein-coding genes[1][3][5][9]. LINC02233 does not encode a protein but may participate in transcriptional or post-transcriptional regulatory processes, consistent with other lincRNAs, which can regulate gene expression, influence chromatin states, and modulate cellular functions[11]. Its HGNC ID is 53104 and it is also known by the alias RP11-6C14.1[1][3][9]. LINC02233 is located at chromosome 4q32[5]. There is currently no evidence confirming LINC02233 as a conventional therapeutic target such as a receptor, enzyme, transporter, or direct participant in established drug mechanisms, nor are there any known drugs that specifically target this lincRNA. Many lincRNAs are under investigation for their biological roles in diseases, including cancer, but no direct biological functions or disease associations (as a biomarker or target) have been firmly established for LINC02233 to date[9][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2233 (LINC02233).